Authors: | Kaelin, W. G.; Sawyers, C. L.; Mihich, E. |
Article Title: | Nineteenth Annual Pezcoller Symposium: Hypothesis-driven clinical investigation in cancer |
Abstract: | This symposium was held in Trento, Italy, from June 14 to 16, 2007, and was cochaired by William G. Kaelin, Enrico Mihich, and Charles L. Sawyers. A session was deveted to the proof of concept derived from successes in target-oriented therapeutics. Molecular targets must be identified in each patients because they are equally present in all patients with the same tumor type. A session was devoted to the identification of markers of drug effectiveness. Two sessions were focused on opportunities for developing new specific molecular target-oriented therapies. ©2007 American Association for Cancer Research. |
Keywords: | cancer survival; gene mutation; erlotinib; drug efficacy; nonhuman; clinical trials as topic; conference paper; neoplasms; cell proliferation; animals; imatinib; dasatinib; chronic myeloid leukemia; drug design; cancer research; oncogene; glioblastoma; fluorodeoxyglucose f 18; gefitinib; cancer relapse; down regulation; drugs, investigational; drug sensitivity; gallium 68 |
Journal Title: | Cancer Research |
Volume: | 67 |
Issue: | 23 |
ISSN: | 0008-5472 |
Publisher: | American Association for Cancer Research |
Date Published: | 2007-12-01 |
Start Page: | 11102 |
End Page: | 11105 |
Language: | English |
DOI: | 10.1158/0008-5472.can-07-3230 |
PUBMED: | 18045966 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Export Date: 17 November 2011" - "CODEN: CNREA" - "Source: Scopus" |